Mycoplasma pneumoniae in children with acute and refractory asthma
- PMID: 23622002
- PMCID: PMC3703852
- DOI: 10.1016/j.anai.2013.01.022
Mycoplasma pneumoniae in children with acute and refractory asthma
Erratum in
- Ann Allergy Asthma Immunol. 2013 Oct;111(4):309
Abstract
Background: The presence of Mycoplasma pneumoniae has been associated with worsening asthma in children. Sensitive assays have been developed to detect M pneumoniae-derived community-acquired respiratory distress syndrome (CARDS) toxin.
Objectives: To identify the frequency and persistence of M pneumoniae detection in respiratory secretions of children with and without asthma and to evaluate antibody responses to M pneumoniae and the impact of M pneumoniae on biological markers, asthma control, and quality of life.
Methods: We enrolled 143 pediatric patients (53 patients with acute asthma, 26 patients with refractory asthma, and 64 healthy controls; age range, 5-17 years) during a 20-month period with 2 to 5 follow-up visits. We detected M pneumoniae using CARDS toxin antigen capture and polymerase chain reaction and P1 adhesin polymerase chain reaction. Immune responses to M pneumoniae were determined by IgG and IgM levels directed against CARDS toxin and P1 adhesin. pH was measured in exhaled breath condensates, and asthma control and quality of life were assessed using the Asthma Control Test and Pediatric Asthma Quality of Life Questionnaire.
Results: M pneumoniae was detected in 64% of patients with acute asthma, 65% with refractory asthma, and 56% of healthy controls. Children with asthma had lower antibody levels to M pneumoniae compared with healthy controls. Exhaled breath condensate pHs and asthma control and quality of life scores were lower in M pneumoniae-positive patients with asthma.
Conclusion: The results suggest that M pneumoniae detection is common in children, M pneumoniae detection is associated with worsening asthma, and children with asthma may have poor humoral immune responses to M pneumoniae.
Copyright © 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.Am J Respir Cell Mol Biol. 2018 Feb;58(2):253-260. doi: 10.1165/rcmb.2017-0006OC. Am J Respir Cell Mol Biol. 2018. PMID: 28915064 Free PMC article.
-
Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.Chest. 2011 Aug;140(2):401-407. doi: 10.1378/chest.11-0221. Epub 2011 May 26. Chest. 2011. PMID: 21622549 Free PMC article.
-
Mycoplasma pneumoniae and health outcomes in children with asthma.Ann Allergy Asthma Immunol. 2017 Aug;119(2):146-152.e2. doi: 10.1016/j.anai.2017.05.022. Epub 2017 Jun 19. Ann Allergy Asthma Immunol. 2017. PMID: 28634021 Free PMC article.
-
Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.Indian J Med Res. 2018 Jan;147(1):23-31. doi: 10.4103/ijmr.IJMR_1582_16. Indian J Med Res. 2018. PMID: 29749357 Free PMC article. Review.
-
Pathogenesis of Mycoplasma pneumoniae: An update.Indian J Med Microbiol. 2016 Jan-Mar;34(1):7-16. doi: 10.4103/0255-0857.174112. Indian J Med Microbiol. 2016. PMID: 26776112 Review.
Cited by
-
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.Emerg Infect Dis. 2020 Jul;26(7):1382-1391. doi: 10.3201/eid2607.200017. Emerg Infect Dis. 2020. PMID: 32568052 Free PMC article.
-
Changes of serum TNF-α, IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma.Int J Clin Exp Med. 2015 Mar 15;8(3):3901-6. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064291 Free PMC article.
-
Bacterial pneumonia in dogs and cats.Vet Clin North Am Small Anim Pract. 2014 Jan;44(1):143-59. doi: 10.1016/j.cvsm.2013.09.003. Vet Clin North Am Small Anim Pract. 2014. PMID: 24268339 Free PMC article. Review.
-
Is asthma an infectious disease? New evidence.Curr Allergy Asthma Rep. 2013 Dec;13(6):702-9. doi: 10.1007/s11882-013-0390-8. Curr Allergy Asthma Rep. 2013. PMID: 24091724 Review.
-
Mycoplasma pneumoniae: A Potentially Severe Infection.J Clin Med Res. 2018 Jul;10(7):535-544. doi: 10.14740/jocmr3421w. Epub 2018 Jun 4. J Clin Med Res. 2018. PMID: 29904437 Free PMC article. Review.
References
-
- Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) Thorax. 2010;76:910–7. - PubMed
-
- Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Annals of Allergy, Asthma & Immunology. 1998;81:339–44. - PubMed
-
- Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158:998–1001. - PubMed
-
- Good JT, Jr, Kolakowski CA, Groshong SD, Murphy JR, Martin RJ. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest. 2012;141:599–606. - PubMed
-
- Leaver R, Weinberg EG. Is Mycoplasma pneumoniae a precipitating factor in acute severe asthma in children? S Afr Med J. 1985;68:78–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical